Jupiter Research Capital (Asia) Ltd’s Trevi Therapeutics TRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$272K Buy
+18,974
New +$326K 0.03% 515

Other funds holding TRVI

Jupiter Research Capital (Asia) Ltd's TRVI Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd opened a new position in Trevi Therapeutics (TRVI) in Q3 2026: 18,974 shares worth $272K. The stake represents 0.03% of the portfolio and ranks #515 among its holdings.

216 funds tracked by Wall St. Rank hold TRVI as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd held 18,974 shares of Trevi Therapeutics worth $272K as of Q3 2026.
  • Trevi Therapeutics was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
  • Trevi Therapeutics made up 0.03% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #515 holding.
  • 216 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.